Importance of Surgical Approach for Gynecological Surgery on Metabolic Effects and Subsequent Recovery
Primary Purpose
Insulin Resistance
Status
Unknown status
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Abdominal hysterectomy
Robot assisted laparoscopic hysterectomy
Sponsored by
About this trial
This is an interventional treatment trial for Insulin Resistance focused on measuring Hysterectomy, Insulin resistance, Metabolism
Eligibility Criteria
Inclusion Criteria:
- Over 18 years of age
- Scheduled to total hysterectomy and/or bilateral salpingo-oophorectomy (BSOE).
- Both malignant or benign indications
- The operation should be technically possible to perform with laparoscopy or by abdominal incision, including approval from an anesthesiologist
- Acceptance to participate in the study and signed written informed consent document
- Proficiency in Swedish language
Exclusion Criteria:
- The operation is anticipated to comprise more than the hysterectomy + BSOE
- Diabetes mellitus
- Severe chronic pain or massive pain medication
- Severe inflammatory disease like active severe endometriosis or inflammatory bowel disease
- Known severe adhesions in the abdomen
- Contraindications on non steroidal analgesia
- Medication with drugs or disease affecting insulin resistance for example cortisone
- Mentally disabled women who cannot fill in the questionnaires or understand the consequences of participating in a trial
- Severe psychiatric disease or on medication for psychiatric disease so that the physician consider participation in the trial inappropriate
Sites / Locations
- Örebro Univeristy HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Robot assisted laparoscopic hysterectomy
Abdominal hysterectomy
Arm Description
Robot assisted laparoscopic total hysterectomy
Standard extrafascial abdominal total hysterectomy through a low transverse abdominal wall incision.
Outcomes
Primary Outcome Measures
Insulin resistance
Insulin resistance is measured by the hyperinsulinemic normoglycemic clamp, a method that now is the golden standard for determining insulin sensitivity. The clamp is measured 1-2 weeks before surgery and on the morning after surgery.
Secondary Outcome Measures
Changes in biomarkers of inflammation and the immune system.
Biomarkers for example IL6 and CRP are measured. Biomarkers are measured two times during the hyperinsulinemic normoglycemic clamp before surgery, 3 hours after surgery and two times during the clamp after surgery.
6 minutes walk test
Measured before surgery and on the day after surgery 25-26 hours after surgery.
postoperative outcomes
Postoperative outcome is registered systematically according to the ERAS Society register.
complications
Adverse events are registered systematically from start of anesthesia to 30 days after surgery
Full Information
NCT ID
NCT02291406
First Posted
November 11, 2014
Last Updated
November 13, 2014
Sponsor
Region Örebro County
1. Study Identification
Unique Protocol Identification Number
NCT02291406
Brief Title
Importance of Surgical Approach for Gynecological Surgery on Metabolic Effects and Subsequent Recovery
Official Title
Importance of Surgical Approach for Hysterectomies on Metabolic Effects Regarding Development of Insulin Resistance and Subsequent Recovery. A Randomized Controlled Study.
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Unknown status
Study Start Date
October 2014 (undefined)
Primary Completion Date
July 2015 (Anticipated)
Study Completion Date
July 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Region Örebro County
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Insulin resistance is a key reaction to surgery and trauma and reflects the degree of metabolic stress. With greater degree of insulin resistance the development of complications increase, in particular infectious complications. The aim of this study is to determine if robotic assisted total laparoscopic hysterectomy induces less insulin resistance compared to abdominal hysterectomy. Insulin resistance is measured by the hyperinsulinemic normoglycemic clamp method. In addition inflammatory factors and clinical recovery will be measured.
Detailed Description
This is a prospective randomized controlled single center study. Primary screening will take place in the gynecological ward of Orebro University hospital according to the inclusion and exclusion criteria. 20 patients will be enrolled. All participants are randomized between robotic assisted total laparoscopic hysterectomy and total abdominal hysterectomy.
The main purpose of this study are to determine if robotic assisted laparoscopic hysterectomy induces less insulin resistance compare to abdominal hysterectomy. Both patients with benign and malignant disease are included. In addition inflammatory factors such as IL-6 and CRP are measured and clinical recovery is measured.
Each patient will be studied twice using the hyperinsulinemic normoglycemic clamp, a method that now is the gold standard for determining insulin sensitivity. During the clamp insulin is infused intravenously to attain an elevation at levels seen after an abnormal meal. At the same time glucose is infused to balance the effect of insulin and to maintain normal blood glucose level. The amount of the glucose infusion needed is the level of insulin sensitivity. The clamp procedure is performed before surgery as a control measure and the morning after surgery to yield the relative change in insulin sensitivity caused by the operation (postoperative insulin resistance). Before the onset of the infusion, and after 60 minutes of steady state during insulin stimulation, blood is collected for the analysis of immune function. This is also collected 3 hours after surgery.
A 6 minutes walk test is performed before surgery and the day after surgery, in order to determine a more clinical measure on recovery.
In addition demographic and clinical data are systematically collected during the hospital stay and 30 days after.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Resistance
Keywords
Hysterectomy, Insulin resistance, Metabolism
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Robot assisted laparoscopic hysterectomy
Arm Type
Active Comparator
Arm Description
Robot assisted laparoscopic total hysterectomy
Arm Title
Abdominal hysterectomy
Arm Type
Active Comparator
Arm Description
Standard extrafascial abdominal total hysterectomy through a low transverse abdominal wall incision.
Intervention Type
Procedure
Intervention Name(s)
Abdominal hysterectomy
Intervention Description
Standard extrafascial abdominal total hysterectomy through a low transverse abdominal wall incision.
Intervention Type
Procedure
Intervention Name(s)
Robot assisted laparoscopic hysterectomy
Intervention Description
Robotic assisted total laparoscopic hysterectomy.
Primary Outcome Measure Information:
Title
Insulin resistance
Description
Insulin resistance is measured by the hyperinsulinemic normoglycemic clamp, a method that now is the golden standard for determining insulin sensitivity. The clamp is measured 1-2 weeks before surgery and on the morning after surgery.
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Changes in biomarkers of inflammation and the immune system.
Description
Biomarkers for example IL6 and CRP are measured. Biomarkers are measured two times during the hyperinsulinemic normoglycemic clamp before surgery, 3 hours after surgery and two times during the clamp after surgery.
Time Frame
3 weeks
Title
6 minutes walk test
Description
Measured before surgery and on the day after surgery 25-26 hours after surgery.
Time Frame
3 weeks
Title
postoperative outcomes
Description
Postoperative outcome is registered systematically according to the ERAS Society register.
Time Frame
4 weeks
Title
complications
Description
Adverse events are registered systematically from start of anesthesia to 30 days after surgery
Time Frame
4 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Over 18 years of age
Scheduled to total hysterectomy and/or bilateral salpingo-oophorectomy (BSOE).
Both malignant or benign indications
The operation should be technically possible to perform with laparoscopy or by abdominal incision, including approval from an anesthesiologist
Acceptance to participate in the study and signed written informed consent document
Proficiency in Swedish language
Exclusion Criteria:
The operation is anticipated to comprise more than the hysterectomy + BSOE
Diabetes mellitus
Severe chronic pain or massive pain medication
Severe inflammatory disease like active severe endometriosis or inflammatory bowel disease
Known severe adhesions in the abdomen
Contraindications on non steroidal analgesia
Medication with drugs or disease affecting insulin resistance for example cortisone
Mentally disabled women who cannot fill in the questionnaires or understand the consequences of participating in a trial
Severe psychiatric disease or on medication for psychiatric disease so that the physician consider participation in the trial inappropriate
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lena Wijk, MD
Phone
+46196022040
Email
lena.wijk@oru.se
First Name & Middle Initial & Last Name or Official Title & Degree
Kerstin Nilsson, MD, PhD
Phone
+46196022389
Email
kerstin.nilsson@orebroll.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kerstin Nilsson, MD, PhD
Organizational Affiliation
Department of Obstetrics and Gynecology, Örebro University Hospital, School of medicine, Örebro University, Sweden
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Lena Wijk, MD
Organizational Affiliation
Department of Obstetrics and Gynecology, Örebro University Hospital, School of Health and Medical Sciences, Örebro University, Sweden
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Olle Ljungqvist, MD, Prof
Organizational Affiliation
Department of Surgery, Örebro University Hospital, School of Health and Medical Sciences Örebro University, Sweden.
Official's Role
Study Chair
Facility Information:
Facility Name
Örebro Univeristy Hospital
City
Örebro
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lena Wijk, MD
Phone
+46196022040
Email
lena.wijk@oru.se
First Name & Middle Initial & Last Name & Degree
Kerstin Nilsson, MD, PhD
Phone
+46196022389
Email
kerstin.nilsson@orebroll.se
12. IPD Sharing Statement
Citations:
PubMed Identifier
28043722
Citation
Wijk L, Nilsson K, Ljungqvist O. Metabolic and inflammatory responses and subsequent recovery in robotic versus abdominal hysterectomy: A randomised controlled study. Clin Nutr. 2018 Feb;37(1):99-106. doi: 10.1016/j.clnu.2016.12.015. Epub 2016 Dec 23.
Results Reference
derived
Learn more about this trial
Importance of Surgical Approach for Gynecological Surgery on Metabolic Effects and Subsequent Recovery
We'll reach out to this number within 24 hrs